Abstract
Short term efficacy and safety of dupilumab for treatment of moderate-to-severe atopic dermatitis in real-world practice: A Canadian retrospective study
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
